18 /100
LOW RISK
Score updated May 29, 2026

AGMB — AgomAb Therapeutics NV Dilution Risk Tracker

Track AGMB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AGMB — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
57
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AGMB.
🔔 Track AGMB — Get forecast alerts →

💹 Market Data

Market Cap$568.32M
Shares Outstanding49.25M
Float16.41M
Cash$135.62M
Debt$1.46M
Short InterestN/A

🏛 Institutional Holdings

48.4% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track AGMB for full holder detail →

📉 Short Interest

Short Interest755.0K
Days to Cover4.4
% of Float4.6%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track AGMB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AGMB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADM
🔬 More Research for AGMB
📊 AGMB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AGMB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.